Clindamycin HCl — Class II drug recall D-0378-2025
Ongoing recall by RemedyRepack Inc., reported 2025-04-30, distributed in PA. CGMP Deviations
| Recall number | D-0378-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | RemedyRepack Inc., Indiana, PA, United States |
| Recall initiated | 2025-03-24 |
| Classified | 2025-04-18 |
| Reported by FDA | 2025-04-30 |
| Distributed | PA |
| Reason classes | cgmp |
| NDC | 70518-3772-00 |
| Lot numbers | J0814691-101624, J0820365-111324, J0826722-121624 |
| Expiration dates | 2025-10-31, 2025-11-30, 2025-12-31 |
Product
Clindamycin HCl, 300 mg Capsule, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC; 70518-3772-00
Reason for recall
CGMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0378-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.